Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Ockham Research (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Charles Schwab Surges on Quarterly Report

% of readers think this story is Fact. Add your two cents.


San Francisco retail brokerage and fund manager Charles Schwab (SCHW) was one of just a few gainers on the NYSE on Friday, soaring more than 6% as broad market indexes slumped more than 2%.  The reason for the rise was the company narrowly topped analysts’ expectations, and they also forecast better times ahead as well.  Revenue came in at $1.08 billion; flat compared to last year but better than Wall Street had estimated at $1.06 billion.  Furthermore, revenue rebounded sharply from the first quarter growing about 10%, reflecting improved interest margin and raised asset management fees.  Net income came in at $205 million or 17 cents per share, which topped average analyst estimates by 2 cents.  Schwab ended the quarter with client assets of $1.36 trillion up 11 percent, as both brokerage and banking accounts experienced growth.

This quarter may mark an important turning point for the company that has struggled under a near zero interest rate environment for more than a year.  In the last quarter short term rates stabilized at a slightly higher level and the net interest margin (the difference between the interest they pay to depositors and that which they are paid for them) widened.  Revenue from interest earned surged to $382 million about a third of overall revenue and 26% better than last year.  Should the economy continue to improve Schwab would likely benefit doubly from a continuation of the interest margin trends as well as further growth in size of client assets.  Management sounded optimistic about the second half of the year, and their ability to grow assets, revenue and earnings going forward.

Schwab also reported gains in trading activity centered around the “flash crash” episode in early May, yet revenues from trading remained a sore spot in the results falling 14 percent for the quarter.  This may perhaps foretell an exodus from equities as fund flows and other data suggest started in the later part of the second quarter.  Indeed, net flows into Schwab’s funds were down $14 billion.  There is no doubt that the company has weathered a difficult period and should benefit from sustained growth in its asset base.  At Ockham, we are reaffirming our Fairly Valued rating on SCHW even as they may be turning a quarter but challenges remain.  Short term interest rates did give the company some relief in the quarter, but with renewed fears of double dip and deflation starting to rear its ugly head, interest rates may remain low for an extended period.  The stock is trading within its historically normal ranges of both price-to-sales and price-to-cash earnings, so there is nothing particularly intriguing from a historical valuation standpoint.

Read the original story at Ockham Research



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login